Christie Smythe and Keri Geiger, Bloomberg:
Martin Shkreli, 32, ignited a firestorm over drug prices in September and became a symbol of defiant greed. The federal case against him has nothing to do with pharmaceutical costs, however. Prosecutors in Brooklyn charged him with illegally taking stock from Retrophin Inc., a biotechnology firm he started in 2011, and using it to pay off debts from unrelated business dealings. He was later ousted from the company, where he’d been chief executive officer, and sued by its board.
I typically don't derive pleasure from the misfortune of others. But exceptions can be made. This guy is arrogant, pretentious, and callous. With his constant bragging and brandishing of his fortune, the childish attention-seeking, the misogyny, and the complete disregard for human life, it's very difficult to have any sort of sympathy for this piece of shit. The fact that it looks like he was dumb enough to commit securities fraud and get caught is just icing on the cake.
I'm sure his Twitter stream will be very entertaining over the next few weeks. People like Shkreli–who think they're more intelligent, more successful, and above everyone else–don't take this sort of thing with any grace or dignity.